Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor N Johnson

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Journal of Clinical Pharmacology|June 1, 2013
Do children have the same vulnerability to metabolic drug–drug interactions as adults? A critical analysis of the literatureFarzaneh Salem, Amin Rostami-Hodjegan, Trevor N Johnson
Biopharmaceutics & Drug Disposition|May 7, 2014
Development of physiologically based pharmacokinetic model to evaluate the relative systemic exposure to quetiapine after administration of IR and XR formulations to adults, children and adolescentsTrevor N Johnson, Diansong Zhou, Khanh H Bui
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 11, 2016
How Does In Vivo Biliary Elimination of Drugs Change with Age? Evidence from In Vitro and Clinical Data Using a Systems Pharmacology ApproachTrevor N Johnson, Masoud Jamei, Karen Rowland-Yeo
Clinical Pharmacokinetics|December 22, 2017
Fetal Physiologically-Based Pharmacokinetic Models: Systems Information on Fetal Biometry and Gross CompositionKhaled Abduljalil, Trevor N Johnson, Amin Rostami-Hodjegan
Clinical Pharmacology and Therapeutics|October 28, 2022
Another Step Toward Qualification of Pediatric Physiologically Based Pharmacokinetic Models to Facilitate Inclusivity and Diversity in Pediatric Clinical StudiesBen G Small, Trevor N Johnson, Karen Rowland Yeo
Pharmaceutics|November 25, 2023
Physiologically Based Pharmacokinetics Modeling in the Neonatal Population-Current Advances, Challenges, and OpportunitiesJean Dinh, Trevor N Johnson, Manuela Grimstein, et al.
Journal of Clinical Pharmacology|July 26, 2023
Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal ExcretionTrevor N Johnson, Khaled Abduljalil, Xian Pan, et al.
Clinical Pharmacokinetics|August 25, 2006
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and childrenTrevor N Johnson, Amin Rostami-Hodjegan, Geoffrey T Tucker
CPT: Pharmacometrics & Systems Pharmacology|February 17, 2022
Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizationsTrevor N Johnson, Ben G Small, Karen Rowland Yeo
The AAPS Journal|April 5, 2014
Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK modelKhaled Abduljalil, Masoud Jamei, Amin Rostami-Hodjegan, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pharmacology|June 1, 2013
Do children have the same vulnerability to metabolic drug–drug interactions as adults? A critical analysis of the literatureFarzaneh Salem, Amin Rostami-Hodjegan, Trevor N Johnson
Biopharmaceutics & Drug Disposition|May 7, 2014
Development of physiologically based pharmacokinetic model to evaluate the relative systemic exposure to quetiapine after administration of IR and XR formulations to adults, children and adolescentsTrevor N Johnson, Diansong Zhou, Khanh H Bui
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 11, 2016
How Does In Vivo Biliary Elimination of Drugs Change with Age? Evidence from In Vitro and Clinical Data Using a Systems Pharmacology ApproachTrevor N Johnson, Masoud Jamei, Karen Rowland-Yeo
Clinical Pharmacokinetics|December 22, 2017
Fetal Physiologically-Based Pharmacokinetic Models: Systems Information on Fetal Biometry and Gross CompositionKhaled Abduljalil, Trevor N Johnson, Amin Rostami-Hodjegan
Clinical Pharmacology and Therapeutics|October 28, 2022
Another Step Toward Qualification of Pediatric Physiologically Based Pharmacokinetic Models to Facilitate Inclusivity and Diversity in Pediatric Clinical StudiesBen G Small, Trevor N Johnson, Karen Rowland Yeo
Pharmaceutics|November 25, 2023
Physiologically Based Pharmacokinetics Modeling in the Neonatal Population-Current Advances, Challenges, and OpportunitiesJean Dinh, Trevor N Johnson, Manuela Grimstein, et al.
Journal of Clinical Pharmacology|July 26, 2023
Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal ExcretionTrevor N Johnson, Khaled Abduljalil, Xian Pan, et al.
Clinical Pharmacokinetics|August 25, 2006
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and childrenTrevor N Johnson, Amin Rostami-Hodjegan, Geoffrey T Tucker
CPT: Pharmacometrics & Systems Pharmacology|February 17, 2022
Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizationsTrevor N Johnson, Ben G Small, Karen Rowland Yeo
The AAPS Journal|April 5, 2014
Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK modelKhaled Abduljalil, Masoud Jamei, Amin Rostami-Hodjegan, et al.
Pageof 8